Imaging dopamine release with Positron Emission Tomography (PET) and 11C-raclopride in freely moving animals

NeuroImage

Volumn 41, Issue 3, 2008, Pages 1051-1066

  Patel, Vinal D ^a   Lee, Dianne E ^a,b   Alexoff, David L ^a   Dewey, Stephen L ^a,b,c   Schiffer, Wynne K ^a,c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Awake; Dopamine; GABA; Gamma vinyl GABA (GVG); Methamphetamine; Positron Emission Tomography (PET); Stress

Indexed keywords

CARBON 11; DOPAMINE; DOPAMINE RECEPTOR; METHAMPHETAMINE; RACLOPRIDE; VIGABATRIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; LOADING DRUG DOSE; MALE; MOLECULAR IMAGING; MOVEMENT (PHYSIOLOGY); NEUROCHEMISTRY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; WAKEFULNESS;

ANIMALS; BRAIN; CARBON RADIOISOTOPES; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; GABA AGENTS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METHAMPHETAMINE; MOVEMENT; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TISSUE DISTRIBUTION; VIGABATRIN;

EID: 44449140352     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.02.065     Document Type: Article

References (85)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., and Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52 (1989) 1655-1658
2. Alexoff D.L., Vaska P., and Logan J. Imaging dopamine receptors in the rat striatum with the MicroPET R4: kinetic analysis of [11C]raclopride binding using graphical methods. Methods Enzymol. 385 (2004) 213-228
3. Badgaiyan R.D., Fischman A.J., and Alpert N.M. Striatal dopamine release in sequential learning. NeuroImage 38 (2007) 549-556
4. Black K.J., Koller J.M., Snyder A.Z., and Perlmutter J.S. Atlas template images for nonhuman primate neuroimaging: baboon and macaque. Methods Enzymol. 385 (2004) 91-102
5. Breier A., Adler C.M., Weisenfeld N., Su T.P., Elman I., Picken L., Malhotra A.K., and Pickar D. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29 (1998) 142-147
6. Brodie J.D., Figueroa E., Laska E.M., and Dewey S.L. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55 (2005) 122-125
7. Cabib S., and Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology 128 (1996) 331-342
8. Carson R.E., Breier A., de Bartolomeis A., Saunders R.C., Su T.P., Schmall B., Der M.G., Pickar D., and Eckelman W.C. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J. Cereb. Blood Flow Metabol. 17 (1997) 437-447
9. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., and Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315 (2007) 1267-1270
10. Dewey S.L., Brodie J.D., Fowler J.S., MacGregor R.R., Schlyer D.J., King P.T., Alexoff D.L., Volkow N.D., Shiue C.Y., and Wolf A.P. Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain. Synapse 6 (1990) 321-327
11. Dewey S.L., Logan J., Wolf A.P., Brodie J.D., Angrist B., Fowler J.S., and Volkow N.D. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse 7 (1991) 324-327
12. Dewey S.L., Smith G.S., Logan J., Brodie J.D., Yu D.W., Ferrieri R.A., King P.T., MacGregor R.R., Martin T.P., and Wolf A.P. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J. Neurosci. 12 (1992) 3773-3780
13. Dewey S.L., Smith G.S., Logan J., Brodie J.D., Fowler J.S., and Wolf A.P. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13 (1993) 350-356
14. Elfving B., Bjornholm B., and Knudsen G.M. Interference of anaesthetics with radioligand binding in neuroreceptor studies. Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 912-915
15. Endres C.J., Kolachana B.S., Saunders R.C., Su T., Weinberger D., Breier A., Eckelman W.C., and Carson R.E. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies. J. Cereb. Blood Flow Metabol. 17 (1997) 932-942
16. Enrico P., Bouma M., de Vries J.B., and Westerink B.H. The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Brain Res. 779 (1998) 205-213
17. Farde L., Hall H., Ehrin E., and Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231 (1986) 258-261
18. Farde L., Wiesel F.A., Halldin C., and Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry 45 (1988) 71-76
19. Feenstra M.G., van der Weij W., and Botterblom M.H. Concentration-dependent dual action of locally applied N-methyl-d-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo. Neurosci. Lett. 201 (1995) 175-178
20. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and Hanson G.R. New insights into the mechanism of action of amphetamines. Ann. Rev. Pharmacol. Toxicol. 47 (2007) 681-698
21. Ford A.P., and Marsden C.A. Influence of anaesthetics on rat striatal dopamine metabolism in vivo. Brain Res. 379 (1986) 162-166
22. Gatley S.J., Volkow N.D., Fowler J.S., Dewey S.L., and Logan J. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine. Synapse 20 (1995) 137-144
23. Gerasimov M.R., Ashby C.R., Gardner E.L., Mills M.J., Brodie J.D., and Dewey S.L. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34 (1999) 11-19
24. Ginovart N., Hassoun W., Le Cavorsin M., Veyre L., Le Bars D., and Leviel V. Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats. Neuropsychopharmacology 27 (2002) 72-84
25. Gunn R.N., Sargent P.A., Bench C.J., Rabiner E.A., Osman S., Pike V.W., Hume S.P., Grasby P.M., and Lammertsma A.A. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 8 (1998) 426-440
26. Hassoun W., Le Cavorsin M., Ginovart N., Zimmer L., Gualda V., Bonnefoi F., and Leviel V. PET study of the [11C]raclopride binding in the striatum of the awake cat: effects of anaesthetics and role of cerebral blood flow. Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 141-148
27. Hauger R.L., Millan M.A., Lorang M., Harwood J.P., and Aguilera G. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology 123 (1988) 396-405
28. Holthoff V.A., Koeppe R.A., Frey K.A., Paradise A.H., and Kuhl D.E. Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil. J. Cereb. Blood Flow Metabol. 11 (1991) 745-752
29. Honer M., Hengerer B., Blagoev M., Hintermann S., Waldmeier P., Schubiger P.A., and Ametamey S.M. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice. Nucl. Med. Biol. 33 (2006) 607-614
30. Houston G.C., Hume S.P., Hirani E., Goggi J.L., and Grasby P.M. Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents. Synapse 51 (2004) 206-212
31. Hume S.P., Gunn R.N., and Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur. J. Nucl. Med. 25 (1998) 173-176
32. Hume S.P., Myers R., Bloomfield P.M., Opacka-Juffry J., Cremer J.E., Ahier R.G., Luthra S.K., Brooks D.J., and Lammertsma A.A. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12 (1992) 47-54
33. Hume S.P., Opacka-Juffry J., Myers R., Ahier R.G., Ashworth S., Brooks D.J., and Lammertsma A.A. Effect of l-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse 21 (1995) 45-53
34. Imperato A., Puglisi-Allegra S., Zocchi A., Scrocco M.G., Casolini P., and Angelucci L. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam. Eur. J. Pharmacol. 175 (1990) 211-214
35. Irifune M., Fukuda T., Nomoto M., Sato T., Kamata Y., Nishikawa T., Mietani W., Yokoyama K., Sugiyama K., and Kawahara M. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Brain Res. 763 (1997) 281-284
36. Kapur S., Barlow K., VanderSpek S.C., Javanmard M., and Nobrega J.N. Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivo. Psychopharmacology 157 (2001) 168-171
37. Kapur S., Wadenberg M.L., and Remington G. Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench [see comments]. Can. J. Psychiatry 45 (2000) 241-246
38. Kawahara Y., Kawahara H., and Westerink B.H. Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn-Schmiedebergs Archives of Pharmacology 360 (1999) 42-49
39. Keita H., Henzel-Rouelle D., Dupont H., Desmonts J.M., and Mantz J. Halothane and isoflurane increase spontaneous but reduce the N-methyl-d-aspartate-evoked dopamine release in rat striatal slices: evidence for direct presynaptic effects. Anesthesiology 91 (1999) 1788-1797
40. Kobayashi K., Inoue O., Watanabe Y., Onoe H., and Langstrom B. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain. J. Neural Transm. Gen. Sect. 100 (1995) 147-151
41. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., and Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 393 (1998) 266-268
42. Kohler C., Hall H., Ogren S.O., and Gawell L. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem. Pharmacol. 34 (1985) 2251-2259
43. Koshikawa N., Tomiyama K., Omiya K., and Kobayashi M. Ketamine anaesthesia has no effect on striatal dopamine metabolism in rats. Brain Res. 444 (1988) 394-396
44. Lannes B., Micheletti G., Warter J.M., Kempf E., and Di Scala G. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. Neurosci. Lett. 128 (1991) 177-181
45. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J. Cereb. Blood Flow Metabol. 20 (2000) 423-451
46. Logan J., Alexoff D., and Kriplani A. Simplifications in analyzing positron emission tomography data: effects on outcome measures. Nucl. Med. Biol. 34 (2007) 743-756
47. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., MacGregor R.R., Hitzemann R., Bendriem B., Gatley S.J., et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metabol. 10 (1990) 740-747
48. Mantz J., Varlet C., Lecharny J.B., Henzel D., Lenot P., and Desmonts J.M. Effects of volatile anesthetics, thiopental, and ketamine on spontaneous and depolarization-evoked dopamine release from striatal synaptosomes in the rat. Anesthesiology 80 (1994) 352-363
49. Marsteller D.A., Gerasimov M.R., Schiffer W.K., Geiger J.M., Barnett C.R., Borg J.S., Scott S., Ceccarelli J., Volkow N.D., Molina P.E., Alexoff D.L., and Dewey S.L. Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex. Neuropsychopharmacology 27 (2002) 163-170
50. Micheletti G., Lannes B., Haby C., Borrelli E., Kempf E., Warter J.M., and Zwiller J. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. Brain Res. Mol. Brain Res. 14 (1992) 363-368
51. Miyano K., Tanifuji Y., and Eger II E.I. The effect of halothane dose on striatal dopamine: an in vivo microdialysis study. Brain Res. 605 (1993) 342-344
52. Momosaki S., Hatano K., Kawasumi Y., Kato T., Hosoi R., Kobayashi K., Inoue O., and Ito K. Rat-PET study without anesthesia: anesthetics modify the dopamine D1 receptor binding in rat brain. Synapse 54 (2004) 207-213
53. 11C]raclopride PET study. Synapse 60 (2006) 124-131
54. 11C-Methylspiperone binding in vivo: Positron emission tomography study using consious rhesus monkey. Brain Res. 663 (1994) 191-198
55. Osborne P.G., O'Connor W.T., Drew K.L., and Ungerstedt U. An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J. Neurosci. Methods 34 (1990) 99-105
56. Pedersen K., Simonsen M., Ostergaard S.D., Lajord Munk O., Rosa-Neto P., Olsen A.K., Jensen S.B., Moller A., and Cumming P. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Neuroimage 35 (2007) 38-46
57. Pothos E.N., Creese I., and Hoebel B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 15 (1995) 6640-6650
58. Pruessner J.C., Champagne F., Meaney M.J., and Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J. Neurosci. 24 (2004) 2825-2831
59. Rodrigues S.F., de Oliveira M.A., Martins J.O., Sannomiya P., de Cassia Tostes R., Nigro D., Carvalho M.H., and Fortes Z.B. Differential effects of chloral hydrate- and ketamine/xylazine-induced anesthesia by the s.c. route. Life Sci. 79 (2006) 1630-1637
60. Rusnak M., Zorad S., Buckendahl P., Sabban E.L., and Kvetnansky R. Tyrosine hydroxylase mRNA levels in locus ceruleus of rats during adaptation to long-term immobilization stress exposure. Mol. Chem. Neuropathol. 33 (1998) 249-258
61. Savaki H.E., Girault J.A., Spampinato U., Truong N.A., Glowinski J., and Besson M.J. Release of newly synthesized 3H-dopamine in the striatum: an adaptation of the push-pull cannula method to awake restrained and anesthetized rats. Brain Res. Bull. 16 (1986) 149-154
62. Schiffer W.K., Gerasimov M.R., Bermel R.A., Brodie J.D., and Dewey S.L. Stereselective inhibition of dopaminergic activity by gamma-vinyl GABA in response to cocaine and nicotine: a PET/microdialysis study. Life Sci. 66 (2000) 169-173 PL
63. Schiffer W.K., Alexoff D.L., Shea C., Logan J., and Dewey S.L. Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging. J. Neurosci. Methods 144 (2005) 25-34
64. Schiffer W.K., Mirrione M.M., Biegon A., Alexoff D.L., Patel V., and Dewey S.L. Serial microPET measures of the metabolic reaction to a microdialysis probe implant. J. Neurosci. Methods 155 (2006) 272-284
65. Schiffer W.K., Mirrione M.M., and Dewey S.L. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. J. Nucl. Med. 48 (2007) 277-287
66. Schwarz A.J., Danckaert A., Reese T., Gozzi A., Paxinos G., Watson C., Merlo-Pich E.V., and Bifone A. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI. NeuroImage 32 (2006) 538-550
67. Schweinhardt P., Fransson P., Olson L., Spenger C., and Andersson J.L. A template for spatial normalisation of MR images of the rat brain. J. Neurosci. Methods 129 (2003) 105-113
68. Shiraishi M., Kamiyama Y., Huttemeier P.C., and Benveniste H. Extracellular glutamate and dopamine measured by microdialysis in the rat striatum during blockade of synaptic transmission in anesthetized and awake rats. Brain Res. 759 (1997) 221-227
69. Smith G.S., Schloesser R., Brodie J.D., Dewey S.L., Logan J., Vitkun S.A., Simkowitz P., Hurley A., Cooper T., Volkow N.D., and Cancro R. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects. Neuropsychopharmacology 18 (1998) 18-25
70. Spampinato U., Girault J.A., Danguir J., Savaki H.E., Glowinski J., and Besson M.J. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats. Brain Res. Bull. 16 (1986) 161-166
71. Stahle L., Collin A.K., and Ungerstedt U. Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study. Naunyn-Schmiedebergs Archives of Pharmacology 342 (1990) 136-140
72. Sun W., Ginovart N., Ko F., Seeman P., and Kapur S. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. Mol. Pharmacol. 63 (2003) 456-462
73. Takeshita H., Okuda Y., and Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology 36 (1972) 69-75
74. Tsukada H., Nishiyama S., Kakiuchi T., Ohba H., Sato K., Harada N., and Nakanishi S. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res. 849 (1999) 85-96
75. Tsukada H., Harada N., Nishiyama S., Ohba H., Sato K., Fukumoto D., and Kakiuchi T. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis. Synapse 37 (2000) 95-103
76. Tsukada H., Miyasato K., Kakiuchi T., Nishiyama S., Harada N., and Domino E.F. Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys. Synapse 45 (2002) 207-212
77. Volkow N.D., Wang G.J., Maynard L., Jayne M., Fowler J.S., Zhu W., Logan J., Gatley S.J., Ding Y.S., Wong C., and Pappas N. Brain dopamine is associated with eating behaviors in humans. Int. J. Eat. Disord. 33 (2003) 136-142
78. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., and Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 26 (2006) 6583-6588
79. Wadenberg M.L., Kapur S., Soliman A., Jones C., and Vaccarino F. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 150 (2000) 422-429
80. Wagner H.N.J., Burns H.D., Dannals R.F., Wong D.F., Langstrom B., Duelfer T., Frost J.J., Ravert H.T., Links J.M., Rosenbloom S.B., Lukas S.E., Kramer A.V., and Kuhar M.J. Imaging dopamine receptors in the human brain by positron tomography. Science 221 (1983) 1264-1266
81. Wong D.F., Kuwabara H., Schretlen D.J., Bonson K.R., Zhou Y., Nandi A., Brasic J.R., Kimes A.S., Maris M.A., Kumar A., Contoreggi C., Links J., Ernst M., Rousset O., Zukin S., Grace A.A., Lee J.S., Rohde C., Jasinski D.R., Gjedde A., and London E.D. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31 (2006) 2716-2727
82. Ylitalo P., Saarnivaara L., and Ahtee L. Effect of ketamine anaesthesia on the content of monoamines and their metabolites in the rat brain. Acta Anaesthesiol. Scand. 20 (1976) 216-220
83. Zald D.H., Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter G.S., and Dagher A. Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 24 (2004) 4105-4112
84. Zelena D., Mergl Z., Foldes A., Kovacs K.J., Toth Z., and Makara G.B. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E1110-E1117
85. Zelena D., Foldes A., Mergl Z., Barna I., Kovacs K.J., and Makara G.B. Effects of repeated restraint stress on hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats. Brain Res. Bull. 63 (2004) 521-530